Parvovirus B19 Antibody (IgM)
Also known as: Human Parvovirus B19 IgM
Use
Detection of IgM-class antibodies to human parvovirus B19 indicates current or recent infection, especially useful in assessing pregnant patients at risk and individuals with anemia or arthropathy.
Special Instructions
Not provided.
Limitations
Limitations not explicitly stated on Quest site; parvovirus IgM tests may be subject to false positives due to cross-reactivity and may require follow‑up testing or paired serology to confirm acute infection.
Methodology
Immunoassay (ELISA)
Biomarkers
Parvovirus B19 IgM antibody
Protein
Result Turnaround Time
2 days
Related Documents
For more information, please review the documents below
Specimen
Serum
Volume
Not provided
Minimum Volume
Not provided
Container
SST tube (yellow‑top)
Collection Instructions
Draw into serum separator tube, centrifuge 30 minutes after draw, refrigerate specimen after collection.
Storage Instructions
Refrigerate after collection.
Stability Requirements
| Temperature | Period |
|---|---|
| Refrigerated | 7 days |
Other tests from different labs that may be relevant